Intersect, the folks behind the new Propel sinus stent, recently presented some findings about the device. The numbers were exceptionally strong across the board, suggesting that implants such as these – and the steroids they use to promote healing – have a positive effect on patient outcomes.
Of the list of presented cases, this section stood out to me:
Keith Matheny, M.D. (Frisco, Texas) presented results of a 20-patient study assessing patient-reported and endoscopic outcomes after placement of the PROPEL steroid releasing implant following sinus surgery during a post-operative office visit. Findings included a statistically significant improvement in patient symptoms observed at four weeks, which were sustained to 12 weeks. Statistically significant reductions were also observed in ethmoid sinus inflammation. The results suggest a therapeutic effect sustained beyond the implant’s biodegradation.
The last part is the meat of the report: not only did Propel confer improvement, but its salutary effects seemed to persist even after removal. This is precisely the sort of value-added benefit we like to see from these devices, particularly since their action only lasts for a few weeks.
To learn more about balloon sinuplasty and the Propel sinus stent, contact the LA sinus surgeons today.